Nothing Special   »   [go: up one dir, main page]

IT1303735B1 - Acidi ialuronici reticolati e loro usi medici. - Google Patents

Acidi ialuronici reticolati e loro usi medici.

Info

Publication number
IT1303735B1
IT1303735B1 IT1998MI002440A ITMI982440A IT1303735B1 IT 1303735 B1 IT1303735 B1 IT 1303735B1 IT 1998MI002440 A IT1998MI002440 A IT 1998MI002440A IT MI982440 A ITMI982440 A IT MI982440A IT 1303735 B1 IT1303735 B1 IT 1303735B1
Authority
IT
Italy
Prior art keywords
cross
linked hyaluronic
hyaluronic acids
medical uses
linked
Prior art date
Application number
IT1998MI002440A
Other languages
English (en)
Inventor
Rolando Barbucci
Roberto Rapuoli
Original Assignee
Falorni Italia Farmaceutici S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11381033&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1303735(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Falorni Italia Farmaceutici S filed Critical Falorni Italia Farmaceutici S
Priority to IT1998MI002440A priority Critical patent/IT1303735B1/it
Priority to PT99968778T priority patent/PT1144459E/pt
Priority to DE69903351T priority patent/DE69903351T3/de
Priority to CZ20011650A priority patent/CZ296842B6/cs
Priority to DK99968778.3T priority patent/DK1144459T4/da
Priority to RU2001112488/04A priority patent/RU2230752C2/ru
Priority to AU26600/00A priority patent/AU757102B2/en
Priority to EP99968778A priority patent/EP1144459B2/en
Priority to KR1020017005929A priority patent/KR100674177B1/ko
Priority to HU0104296A priority patent/HU229668B1/hu
Priority to US09/830,761 priority patent/US6831172B1/en
Priority to CN99813143A priority patent/CN1131241C/zh
Priority to BR9915235-5A priority patent/BR9915235A/pt
Priority to AT99968778T priority patent/ATE225371T1/de
Priority to CA002350667A priority patent/CA2350667A1/en
Priority to TR2001/01324T priority patent/TR200101324T2/xx
Priority to IL14306399A priority patent/IL143063A0/xx
Priority to ES99968778T priority patent/ES2184521T5/es
Priority to JP2000581064A priority patent/JP2002529550A/ja
Priority to PCT/EP1999/008481 priority patent/WO2000027887A2/en
Priority to NZ511306A priority patent/NZ511306A/en
Publication of ITMI982440A1 publication Critical patent/ITMI982440A1/it
Publication of IT1303735B1 publication Critical patent/IT1303735B1/it
Application granted granted Critical
Priority to ZA200103799A priority patent/ZA200103799B/en
Priority to NO20012315A priority patent/NO20012315L/no
Priority to HK02102744.3A priority patent/HK1041011B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
IT1998MI002440A 1998-11-11 1998-11-11 Acidi ialuronici reticolati e loro usi medici. IT1303735B1 (it)

Priority Applications (24)

Application Number Priority Date Filing Date Title
IT1998MI002440A IT1303735B1 (it) 1998-11-11 1998-11-11 Acidi ialuronici reticolati e loro usi medici.
BR9915235-5A BR9915235A (pt) 1998-11-11 1999-11-08 ácidos hialurÈnicos reticulados e usos médicos dos mesmos
CA002350667A CA2350667A1 (en) 1998-11-11 1999-11-08 Cross-linked hyaluronic acids and medical uses thereof
CZ20011650A CZ296842B6 (cs) 1998-11-11 1999-11-08 Zesítené hyaluronové kyseliny
DK99968778.3T DK1144459T4 (da) 1998-11-11 1999-11-08 Tværbundne hyaluronsyrer og medicinske anvendelser deraf
RU2001112488/04A RU2230752C2 (ru) 1998-11-11 1999-11-08 Поперечносшитые гиалуроновые кислоты и их применение в медицине
AU26600/00A AU757102B2 (en) 1998-11-11 1999-11-08 Cross-linked hyaluronic acids and medical uses thereof
EP99968778A EP1144459B2 (en) 1998-11-11 1999-11-08 Cross-linked hyaluronic acids and medical uses thereof
KR1020017005929A KR100674177B1 (ko) 1998-11-11 1999-11-08 교차 결합된 히알루론산과 그것의 의학적 용도
HU0104296A HU229668B1 (en) 1998-11-11 1999-11-08 Cross-linked hyaluronic acids, uses thereof and biological substances containing them
US09/830,761 US6831172B1 (en) 1998-11-11 1999-11-08 Cross-linked hyaluronic acids and medical uses thereof
CN99813143A CN1131241C (zh) 1998-11-11 1999-11-08 交联的透明质酸和它在医药方面的应用
PT99968778T PT1144459E (pt) 1998-11-11 1999-11-08 Acidos hialuronicos reticulados e as suas utilizacoes em medicina
AT99968778T ATE225371T1 (de) 1998-11-11 1999-11-08 Vernetzte hyaluronsäure und ihre medizinischen verwendungen
DE69903351T DE69903351T3 (de) 1998-11-11 1999-11-08 Vernetzte hyaluronsäure und ihre medizinischen verwendungen
TR2001/01324T TR200101324T2 (tr) 1998-11-11 1999-11-08 Çapraz bağlanmış hialuronik asitler ve bunların tıbbi kullanımları
IL14306399A IL143063A0 (en) 1998-11-11 1999-11-08 Cross-linked hyaluronic acids and medical uses thereof
ES99968778T ES2184521T5 (es) 1998-11-11 1999-11-08 Ácidos hialurónicos reticulados y sus usos médicos.
JP2000581064A JP2002529550A (ja) 1998-11-11 1999-11-08 架橋ヒアルロン酸及びその医療上の使用
PCT/EP1999/008481 WO2000027887A2 (en) 1998-11-11 1999-11-08 Cross-linked hyaluronic acids and medical uses thereof
NZ511306A NZ511306A (en) 1998-11-11 1999-11-08 Cross-linked hyaluronic acids obtained by reaction of activated carboxy groups of hyaluronic acid (HY) with a polyamine
ZA200103799A ZA200103799B (en) 1998-11-11 2001-05-10 Cross-linked hyaluronic acids and medical uses thereof.
NO20012315A NO20012315L (no) 1998-11-11 2001-05-10 Fornettede hyaluronsyrer og medisinske anvendelser derav
HK02102744.3A HK1041011B (zh) 1998-11-11 2002-04-11 交聯的透明質酸和它在醫藥方面的應用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998MI002440A IT1303735B1 (it) 1998-11-11 1998-11-11 Acidi ialuronici reticolati e loro usi medici.

Publications (2)

Publication Number Publication Date
ITMI982440A1 ITMI982440A1 (it) 2000-05-11
IT1303735B1 true IT1303735B1 (it) 2001-02-23

Family

ID=11381033

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1998MI002440A IT1303735B1 (it) 1998-11-11 1998-11-11 Acidi ialuronici reticolati e loro usi medici.

Country Status (24)

Country Link
US (1) US6831172B1 (it)
EP (1) EP1144459B2 (it)
JP (1) JP2002529550A (it)
KR (1) KR100674177B1 (it)
CN (1) CN1131241C (it)
AT (1) ATE225371T1 (it)
AU (1) AU757102B2 (it)
BR (1) BR9915235A (it)
CA (1) CA2350667A1 (it)
CZ (1) CZ296842B6 (it)
DE (1) DE69903351T3 (it)
DK (1) DK1144459T4 (it)
ES (1) ES2184521T5 (it)
HK (1) HK1041011B (it)
HU (1) HU229668B1 (it)
IL (1) IL143063A0 (it)
IT (1) IT1303735B1 (it)
NO (1) NO20012315L (it)
NZ (1) NZ511306A (it)
PT (1) PT1144459E (it)
RU (1) RU2230752C2 (it)
TR (1) TR200101324T2 (it)
WO (1) WO2000027887A2 (it)
ZA (1) ZA200103799B (it)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD980037A1 (it) * 1998-02-25 1999-08-25 Fidia Advanced Biopolymers Srl Acido ialuronico solfatato e i suoi derivati legati covalentemente a polimeri sintetici pe la preparazione di biomateriali e per il rivesti
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
US7068729B2 (en) 2001-12-21 2006-06-27 Digital Fountain, Inc. Multi-stage code generator and decoder for communication systems
US6307487B1 (en) 1998-09-23 2001-10-23 Digital Fountain, Inc. Information additive code generator and decoder for communication systems
IT1303738B1 (it) * 1998-11-11 2001-02-23 Aquisitio S P A Processo di reticolazione di polisaccaridi carbossilati.
EP1140198B1 (en) 1999-01-13 2007-10-31 Alchemia Oncology Pty Limited Use of hyaluronan for the manufacture of a medicament for the enhancement of the efficacy of cytotoxic drugs
KR100338179B1 (ko) * 2000-05-08 2002-05-24 김범철 안질환 치료용 약물 전달을 위한 그래프트 중합체 및 그제조방법
AUPQ879500A0 (en) * 2000-07-14 2000-08-10 Meditech Research Limited Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
US9066919B2 (en) * 2000-07-14 2015-06-30 Alchemia Oncology Pty Limited Hyaluronan as a chemo-sensitizer in the treatment of cancer
KR100375299B1 (ko) * 2000-10-10 2003-03-10 주식회사 엘지생명과학 히알루론산의 가교결합형 아마이드 유도체와 이의 제조방법
US7128904B2 (en) 2001-01-16 2006-10-31 The Regents Of The University Of Michigan Material containing metal ion ligand complex producing nitric oxide in contact with blood
US7335383B2 (en) 2001-01-16 2008-02-26 The Regents Of The University Of Michigan Generation of nitric oxide in vivo from nitrite, nitrate or nitrosothiols endogenous in blood
WO2002056904A1 (en) * 2001-01-16 2002-07-25 The Regents Of The University Of Michigan Biocatalytic and biomimetic generation of nitric oxide in situ at substrate/blood interfaces
CN1578677A (zh) * 2001-08-27 2005-02-09 美迪泰克研究有限公司 改良的治疗方案
US9240810B2 (en) 2002-06-11 2016-01-19 Digital Fountain, Inc. Systems and processes for decoding chain reaction codes through inactivation
KR20040009891A (ko) * 2002-07-26 2004-01-31 주식회사 엘지생명과학 히알루론산의 유도체 겔 및 그 제조방법
EP2355360B1 (en) 2002-10-05 2020-08-05 QUALCOMM Incorporated Systematic encoding and decoding of chain reaction codes
AU2003286660A1 (en) * 2002-10-25 2004-05-13 Essentia Biosystems, Inc. Implantable medical devices using zinc
FR2850282B1 (fr) 2003-01-27 2007-04-06 Jerome Asius Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation
WO2004081055A1 (ja) * 2003-02-21 2004-09-23 Terumo Kabushiki Kaisha 架橋性多糖誘導体、その製造方法、架橋性多糖組成物および医療用処置材
JP2004262777A (ja) * 2003-02-27 2004-09-24 Shiseido Co Ltd アセチル化ヒアルロン酸含有眼用医薬組成物
NZ542494A (en) * 2003-04-04 2009-03-31 Nobil Bio Ricerche Srl Vascular stent
KR101183843B1 (ko) 2003-10-06 2012-09-19 디지털 파운튼, 인크. 단일 송신기 또는 다중 송신기를 갖는 통신 시스템의 에러정정 다중-스테이지 코드 생성기 및 디코더
ES2406555T3 (es) * 2003-10-29 2013-06-07 Teijin Limited Compuesto de ácido hialurónico, hidrogel del mismo y material para tratar articulaciones
US20090148527A1 (en) * 2007-12-07 2009-06-11 Robinson Michael R Intraocular formulation
JP4971144B2 (ja) 2004-05-07 2012-07-11 デジタル ファウンテン， インコーポレイテッド ファイルダウンロードおよびストリーミングのシステム
ITMI20041373A1 (it) 2004-07-09 2004-10-09 Lima Lto S P A N-metil-ammidi di carbossimetilcellulosa acido alginico o carbossimetalamido
JP5060131B2 (ja) * 2004-09-07 2012-10-31 中外製薬株式会社 水溶性ヒアルロン酸修飾物の製造方法
CN101056891B (zh) * 2004-11-15 2010-05-26 株式会社资生堂 交联透明质酸凝胶的制备方法
PT1817347T (pt) * 2004-11-24 2017-07-21 Albumedix As Resumo
EP1833882A1 (en) * 2004-12-30 2007-09-19 Novozymes Biopolymer A/S Hyaluronic acid linked with a polymer of an alpha hydroxy acid
ITPD20050056A1 (it) * 2005-03-02 2006-09-03 Fidia Farmaceutici Derivati ammidici del'acido ialuronico in osteoartrosi
TW200643033A (en) * 2005-03-08 2006-12-16 Chugai Pharmaceutical Co Ltd Conjugate of water-soluble modified hyaluronic acid and glp-1 analogue
US7676735B2 (en) 2005-06-10 2010-03-09 Digital Fountain Inc. Forward error-correcting (FEC) coding and streaming
WO2007012133A1 (en) 2005-07-27 2007-02-01 Alchemia Oncology Pty Limited Therapeutic protocols using hyaluronan
JP5627181B2 (ja) 2005-09-07 2014-11-19 アルケミア オンコロジー ピーティーワイ リミテッド ヒアルロナンおよび治療用抗体を含む治療用組成物ならびに治療方法
US7879818B2 (en) * 2005-12-23 2011-02-01 Janos Borbely Hyaluronic acid-based cross-linked nanoparticles
KR100737954B1 (ko) * 2006-01-03 2007-07-13 고려대학교 산학협력단 조직재생을 위한 히알루론산-기초된 주사형 하이드로겔
WO2007095550A2 (en) 2006-02-13 2007-08-23 Digital Fountain, Inc. Streaming and buffering using variable fec overhead and protection periods
US9270414B2 (en) 2006-02-21 2016-02-23 Digital Fountain, Inc. Multiple-field based code generator and decoder for communications systems
WO2007101243A1 (en) * 2006-02-28 2007-09-07 Novozymes Biopolymer A/S Derivatives of hyaluronic acids
US7674781B2 (en) * 2006-04-28 2010-03-09 Heather Sheardown Hyaluronic acid-retaining polymers
WO2007134196A2 (en) 2006-05-10 2007-11-22 Digital Fountain, Inc. Code generator and decoder using hybrid codes
US9209934B2 (en) 2006-06-09 2015-12-08 Qualcomm Incorporated Enhanced block-request streaming using cooperative parallel HTTP and forward error correction
US9432433B2 (en) 2006-06-09 2016-08-30 Qualcomm Incorporated Enhanced block-request streaming system using signaling or block creation
US9386064B2 (en) 2006-06-09 2016-07-05 Qualcomm Incorporated Enhanced block-request streaming using URL templates and construction rules
US9419749B2 (en) 2009-08-19 2016-08-16 Qualcomm Incorporated Methods and apparatus employing FEC codes with permanent inactivation of symbols for encoding and decoding processes
US9178535B2 (en) 2006-06-09 2015-11-03 Digital Fountain, Inc. Dynamic stream interleaving and sub-stream based delivery
US9380096B2 (en) 2006-06-09 2016-06-28 Qualcomm Incorporated Enhanced block-request streaming system for handling low-latency streaming
CA2657823A1 (en) * 2006-08-04 2008-02-07 Novozymes Biopolymer A/S Branched hyaluronic acid and method of manufacture
US20080070993A1 (en) * 2006-09-07 2008-03-20 Janos Borbely Additives for cosmetic products and the like
FR2909285A1 (fr) * 2006-12-01 2008-06-06 Anteis Sa "utilisation d'un gel anti-adhesif et anti fibrotique"
FR2909560B1 (fr) * 2006-12-06 2012-12-28 Fabre Pierre Dermo Cosmetique Gel d'acide hyaluronique pour injection intradermique
JP2008255061A (ja) * 2007-04-06 2008-10-23 Shiseido Co Ltd 可溶性架橋ヒアルロン酸含有眼用組成物
US20090023631A1 (en) * 2007-07-18 2009-01-22 Lorenc Z Paul Composition and Method of Use for Soft Tissue Augmentation/Drug Delivery
US8563514B2 (en) * 2007-08-15 2013-10-22 Metamorefix Peptides and pharmaceutical compositions for treating connective tissue
AU2008298602A1 (en) 2007-09-12 2009-03-19 Digital Fountain, Inc. Generating and communicating source identification information to enable reliable communications
CN102177180A (zh) 2008-04-04 2011-09-07 犹他州大学研究基金会 烷基化半合成的糖胺聚糖醚及其制备和使用方法
US8932622B2 (en) * 2008-06-03 2015-01-13 Actamax Surgical Materials, Llc Tissue coating for preventing undesired tissue-to-tissue adhesions
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
AU2009280306B2 (en) * 2008-08-05 2014-08-07 Teijin Limited Hydrogel
US20100104654A1 (en) 2008-10-27 2010-04-29 Allergan, Inc. Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
FR2938187B1 (fr) * 2008-11-07 2012-08-17 Anteis Sa Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur
US9281847B2 (en) 2009-02-27 2016-03-08 Qualcomm Incorporated Mobile reception of digital video broadcasting—terrestrial services
US9288010B2 (en) 2009-08-19 2016-03-15 Qualcomm Incorporated Universal file delivery methods for providing unequal error protection and bundled file delivery services
IT1395392B1 (it) * 2009-08-27 2012-09-14 Fidia Farmaceutici Geli viscoelastici come nuovi filler
US9917874B2 (en) 2009-09-22 2018-03-13 Qualcomm Incorporated Enhanced block-request streaming using block partitioning or request controls for improved client-side handling
JP5604072B2 (ja) * 2009-09-28 2014-10-08 テルモ株式会社 活性エステル化多糖およびその製造方法
FR2954945B1 (fr) 2010-01-04 2012-01-06 Oreal Composition cosmetique ou dermatologique, procede de traitement cosmetique et derive d'acide hyaluronique
US20110280311A1 (en) 2010-05-13 2011-11-17 Qualcomm Incorporated One-stream coding for asymmetric stereo video
US9017712B2 (en) * 2010-07-12 2015-04-28 Shin Poong Pharmaceutical Co., Ltd. Filler composition for tissue reinforcement
US9596447B2 (en) 2010-07-21 2017-03-14 Qualcomm Incorporated Providing frame packing type information for video coding
US8806050B2 (en) 2010-08-10 2014-08-12 Qualcomm Incorporated Manifest file updates for network streaming of coded multimedia data
US9270299B2 (en) 2011-02-11 2016-02-23 Qualcomm Incorporated Encoding and decoding using elastic codes with flexible source block mapping
US8958375B2 (en) 2011-02-11 2015-02-17 Qualcomm Incorporated Framing for an improved radio link protocol including FEC
CA2830933A1 (en) 2011-03-23 2012-09-27 University Of Utah Research Foundation Methods for treating or preventing urological inflammation
RU2477155C2 (ru) * 2011-04-27 2013-03-10 Закрытое акционерное общество "Патент-Фарм" Способ лечения андрогенетической алопеции
US9253233B2 (en) 2011-08-31 2016-02-02 Qualcomm Incorporated Switch signaling methods providing improved switching between representations for adaptive HTTP streaming
US9843844B2 (en) 2011-10-05 2017-12-12 Qualcomm Incorporated Network streaming of media data
CZ303879B6 (cs) * 2012-02-28 2013-06-05 Contipro Biotech S.R.O. Deriváty na bázi kyseliny hyaluronové schopné tvorit hydrogely, zpusob jejich prípravy, hydrogely na bázi techto derivátu, zpusob jejich prípravy a pouzití
US9294226B2 (en) 2012-03-26 2016-03-22 Qualcomm Incorporated Universal object delivery and template-based file delivery
FR2997014B1 (fr) 2012-10-24 2015-03-20 Teoxane Composition sterile dermo-injectable
FR3005056B1 (fr) * 2013-04-24 2016-04-01 Ayawane Hydrogel a base de polysaccharides natifs et/ou fonctionnalises, phosphates co-reticules
AU2014301493B2 (en) * 2013-06-28 2018-11-29 Galderma S.A. A process for preparing a cross-linked hyaluronic acid product
US9421198B2 (en) 2013-07-30 2016-08-23 Teoxane Composition comprising hyaluronic acid and mepivacaine
ITUD20130119A1 (it) * 2013-09-12 2015-03-13 Limacorporate Spa Idrogel biocompatibile per uso biomedico o farmaceutico, polimero intermedio per realizzare detto idrogel biocompatibile e relativo metodo di realizzazione
EP3068408A4 (en) * 2013-11-14 2017-09-06 University Medical Pharmaceuticals Corporation Microneedles for therapeutic agent delivery with improved mechanical properties
EP3101064B1 (en) * 2014-01-31 2020-07-15 Seikagaku Corporation Diamine crosslinking agent, acidic polysaccharide crosslinked body, and medical material
ES2810013T3 (es) 2015-12-29 2021-03-08 Galderma Sa Reticulante de carbohidratos
WO2018053111A1 (en) 2016-09-15 2018-03-22 University Of Utah Research Foundation In situ gelling compositions for the treatment or prevention of inflammation and tissue damage
AU2017329872A1 (en) * 2016-09-21 2019-04-11 Nestlé Skin Health Sa Hyaluronic acid gel with a divalent zinc cation
CA3055985A1 (en) 2017-03-22 2018-09-27 Genentech, Inc. Hydrogel cross-linked hyaluronic acid prodrug compositions and methods
WO2019001784A1 (en) 2017-06-28 2019-01-03 Nestlé Skin Health Sa HYALURONIC ACID GEL WITH A DIVALENT CATION
CN107469090B (zh) * 2017-08-15 2020-05-12 浙江大学 可共载抗肿瘤药物和核酸药物的纳米载体及抗肿瘤药物纳米制剂
CN111228653A (zh) 2018-11-13 2020-06-05 格莱科米拉治疗公司 用电离辐射加强癌症治疗的方法
EP3659632A1 (en) 2018-11-29 2020-06-03 Nestlé Skin Health SA Post-crosslinking partial degradation of amide crosslinked hydrogels
WO2020212920A1 (en) * 2019-04-19 2020-10-22 Jointherapeutics Srl Crosslinked polymer of functionalized hyaluronic acid and its use in the treatment of inflammatory states
CN110123741B (zh) * 2019-06-24 2022-02-08 中国医学科学院基础医学研究所 一种铁交联透明质酸纳米凝胶、其制备方法以及用途
CN110684211B (zh) * 2019-10-14 2022-07-12 宁夏妙朗生物科技有限公司 制备抵抗α-葡萄糖苷酶水解的交联右旋糖苷凝胶的方法
BR112022010831A2 (pt) 2019-12-02 2022-08-23 Galderma Holding SA Composições estéticas de alto peso molecular
WO2022109050A1 (en) * 2020-11-18 2022-05-27 Bexson Biomedical, Inc. Complexing agent salt formulations of pharmaceutical compounds
JP2023551145A (ja) 2020-11-18 2023-12-07 ベクソン バイオメディカル，インク． 医薬化合物の錯化剤塩製剤
WO2023148619A1 (en) 2022-02-01 2023-08-10 Galderma Holding SA Methods of producing crosslinked hyaluronic acid hydrogels
CN114561046B (zh) * 2022-02-28 2023-10-27 江南大学 一种胍基透明质酸型抗菌水凝胶及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
ES2048133T3 (es) * 1990-05-04 2000-01-16 Perio Prod Ltd Sistema de descarga de farmacos para el colon.
SG81873A1 (en) * 1991-08-16 2001-07-24 Miles A Galin Medicament coated refractive anterior chamber ocular implant
IT1254170B (it) * 1991-12-18 1995-09-11 Mini Ricerca Scient Tecnolog Membrane composite per la rigenerazione guidata di tessuti
CA2076732C (en) * 1992-04-17 2006-05-09 Kimberly-Clark Worldwide, Inc. Modified polysaccharides having improved absorbent properties and process for the preparation thereof
JPH06154596A (ja) * 1992-11-18 1994-06-03 Sanyo Chem Ind Ltd 耐塩安定性吸収剤及びその製法
US5616568A (en) * 1993-11-30 1997-04-01 The Research Foundation Of State University Of New York Functionalized derivatives of hyaluronic acid
JPH0959303A (ja) * 1995-08-22 1997-03-04 Shiseido Co Ltd 生体適合性ヒアルロン酸ゲル及びその用途
FR2752843B1 (fr) * 1996-08-30 1998-10-16 Sod Conseils Rech Applic Copolymeres reticules a base de polymeres polycarboxyliques et leur utilisation comme support de composition pharmaceutique
IT1303738B1 (it) * 1998-11-11 2001-02-23 Aquisitio S P A Processo di reticolazione di polisaccaridi carbossilati.

Also Published As

Publication number Publication date
HU229668B1 (en) 2014-04-28
BR9915235A (pt) 2001-07-24
NZ511306A (en) 2003-05-30
ES2184521T5 (es) 2011-06-13
IL143063A0 (en) 2002-04-21
DE69903351T2 (de) 2003-07-03
ES2184521T3 (es) 2003-04-01
ATE225371T1 (de) 2002-10-15
KR20010101001A (ko) 2001-11-14
HUP0104296A2 (hu) 2002-03-28
CZ20011650A3 (cs) 2001-09-12
PT1144459E (pt) 2003-01-31
WO2000027887A3 (en) 2000-11-16
TR200101324T2 (tr) 2001-09-21
HUP0104296A3 (en) 2003-12-29
WO2000027887A2 (en) 2000-05-18
NO20012315L (no) 2001-07-06
HK1041011A1 (en) 2002-06-28
RU2230752C2 (ru) 2004-06-20
HK1041011B (zh) 2004-10-08
DK1144459T3 (da) 2003-02-03
EP1144459A2 (en) 2001-10-17
EP1144459B2 (en) 2011-02-23
CN1131241C (zh) 2003-12-17
DE69903351T3 (de) 2012-02-09
DE69903351D1 (de) 2002-11-07
US6831172B1 (en) 2004-12-14
NO20012315D0 (no) 2001-05-10
AU2660000A (en) 2000-05-29
AU757102B2 (en) 2003-01-30
JP2002529550A (ja) 2002-09-10
ITMI982440A1 (it) 2000-05-11
CA2350667A1 (en) 2000-05-18
EP1144459B1 (en) 2002-10-02
ZA200103799B (en) 2002-08-12
KR100674177B1 (ko) 2007-01-24
CN1328573A (zh) 2001-12-26
CZ296842B6 (cs) 2006-06-14
DK1144459T4 (da) 2011-06-06

Similar Documents

Publication Publication Date Title
IT1303735B1 (it) Acidi ialuronici reticolati e loro usi medici.
BR9508031A (pt) Composto antiviral composição farmacéutica ou veterinária e processo para o tratamento antiviral profilático ou terapéuitco de um humano ou animal náo humano e uso do composto
EE200200130A (et) Uued farmatseutiliste omadustega aminodikarboksüülhappe derivaadid
DK1163274T3 (da) Fremgangsmåde til tværbinding af hyaluronsyre til polymerer
TR199800849T2 (xx) Siklikle heterosiklik N-ikame edilmi� alfa-iminohidroksamla karbon asitleri
DE60012176D1 (de) Polymerisation von fluoropolymeren
HUP0004230A2 (hu) Probucol monoésztereinek alkalmazása VCAM-1 gátlására alkalmas gyógyászati készítmények előállítására
CR9430A (es) N-hidroxiamidas omega-sustituidas con grupos triciclos como inhibidores de histona desacetilasa, su preparacion y uso en formulaciones farmaceuticas
NO20022728D0 (no) Nye aminopropylfosfinsyrer
DZ3197A1 (fr) Acides aminés bicycliques utilises comme agents pharmaceutiques.
HUP0203914A2 (en) High order nucleic acid based structures
NO20021969D0 (no) Gassfase-polymerisasjonsprosess
FI944506A (fi) Menetelmä alkeenipolymeerien valmistamiseksi
AU3524800A (en) Polycyclic polymers containing pendant cyclic anhydride groups
FR2794757B1 (fr) Procede de polymerisation de l'isobutene
FI970679A0 (fi) Hydroksialkaanihapoista muodostettujen polymeerien valmistus
DK1180094T3 (da) Kondenserede polycykliske aminosyrer som farmaceutiske midler
TR199600583A2 (tr) Farmasötik aktiviteye sahip -amino asitlerin tolere edilebilirliginin arttirilmasi.
IL146923A0 (en) Oligomers and polymers of cyclic imino carboxylic acids
IT1312536B1 (it) Procedimento per la produzione e purificazione di acidi aromatici.
ITTO930519A1 (it) Procedimento di sintesi di acidi cloroacetici.
IT1307976B1 (it) Processo per la preparazione di acidi benzofenonsolfonici.
IT1319169B1 (it) Procedimento per la purificazione di acidi carbossilici aromatici.
BR9612137A (pt) Conjugados covalentes de lipídio-ácido fosfono carboxílico sua produção bem como sua utilização como agentes farmaceuticos antivirais
DE60135311D1 (de) Katalysatorkomponente fur die polymerisation von olefinen